Genome Researchers Raise Alarm Over Big Data
By Erika Check Hayden,
Nature News
| 07. 07. 2015
Untitled Document
The computing resources needed to handle genome data will soon exceed those of Twitter and YouTube, says a team of biologists and computer scientists who are worried that their discipline is not geared up to cope with the coming genomics flood.
Other computing experts say that such a comparison with other ‘big data’ areas is not convincing and a little glib. But they agree that the computing needs of genomics will be enormous as sequencing costs drop and ever more genomes are analysed.
By 2025, between 100 million and 2 billion human genomes could have been sequenced, according to the report1, which is published in the journal PLoS Biology. The data-storage demands for this alone could run to as much as 2–40 exabytes (1 exabyte is 1018 bytes), because the number of data that must be stored for a single genome are 30 times larger than the size of the genome itself, to make up for errors incurred during sequencing and preliminary analysis.
The team says that this outstrips YouTube’s projected annual storage needs of...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...